CHAIR
Spencer B. King, III, MD
President
St. Joseph's Hospital
Heart & Vascular Institute
Professor of Medicine Emeritus
Emory University
School of Medicine
Atlanta, Georgia

PANELISTS
James B. Hermiller, MD
Director
Cardiac Catheterization Labs
The Care Group
St. Vincent Hospital
Indianapolis, Indiana

Gregg W. Stone, MD
Professor of Medicine
Director of Research and Education
Center for Interventional Vascular Therapy
New York-Presbyterian Hospital
Columbia University Medical Center
The Cardiovascular Research Foundation
New York, NY

Ian T. Meredith, MBBS, PhD
Professor of Cardiology
Monash University
Director of Cardiology
Monash Medical Centre
Melbourne, Australia

Monday, March 15, 2010
7:00 PM – 7:30 PM Registration and cocktails
7:30 PM – 8:30 PM Scientific program
LOCATION
Omni Hotel
100 CNN Center Atlanta, GA
Room: International Ballroom F-M2- North tower

AGENDA
Welcome and Introduction
Spencer B. King, III, MD

Drug-Eluting Stents in Coronary Artery Disease: Where Does the Evidence Lead Us?
James B. Hermiller, MD

Dual Antiplatelet Therapy in PCI: Strategies for Risk Reduction in Drug-Eluting Stent Patients
Gregg W. Stone, MD

Bioabsorbable Stents: Do the Data Show Promise in Coronary Artery Disease?
Ian T. Meredith, MBBS, PhD

REGISTRATION
Fields marked with an asterisk(*) are obligatory. Please refrain from using any symbols as you fill out the fields.
First name*
 Last name*
Degree*
 Title
Affiliation*
 Business address*
City*
 State / Province*
Country
Zip / Postal code*
Business phone
 Business Fax
Email*


 Profession *




DISCLAIMER
This event is not part of the official American College of Cardiology (ACC) Annual Scientific Session and/or the ACC's Innovation in Intervention: i2 Summit in partnership with the Cardiovascular Research Foundation, as planned by their program committees.

PURPOSE / GOAL
The purpose of this educational event is to educate clinicians on recent efficacy and safety data of DES in percutaneous coronary intervention and strategies to optimize antiplatelet therapy, and discuss the role of bioabsorbable stents.

TARGET AUDIENCE
This program is intended for general and interventional cardiologists and allied health professionals who manage and treat patients who have coronary artery disease with stents.

EDUCATIONAL OBJECTIVES
After completing the program, the participant will be able to:
  • Discuss recent data comparing outcomes in patients treated with various drug-eluting stents (DES)
  • Develop strategies to manage the risks and benefits of long-term dual antiplatelet therapy in patients receiving DES
  • Review the potential role and limitations of bioabsorbable stents in the management of patients undergoing revascularization
ACCREDITATION STATEMENT

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Each participant should only claim credit commensurate with the extent of their participation in the activity.

For questions or assistance, please contact CME@medscape.net.

COMMERCIAL SUPPORT ACKNOWLEDGEMENT
This educational activity is supported by an independent educational grant from Abbott Vascular.